Patients With Severe Acute Exacerbation of COPD Ans Admitted in ICU Register.
Recruiting · NCT06257329 · Observational (researchers observe without assigning treatment) · Lead sponsor: Alexis FERRE
View the official record on ClinicalTrials.gov →Interventions studied
register
What this trial is about
The objective of this prospective observational study is to describe the epidemiological, clinical and biological characteristics of admitted patients in ICU for severe acute exacerbation of COPD, to assess the different therapeutics used, to evaluate the prognosis of patients with short, medium and long term ( 1 year) and the various factors associated with survival in ICU
Who can take part
Age range
40 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age ≥ 40 years old
- COPD documented or strongly suspected
- Chronic respiratory symptoms (dyspnoea, cough and/or sputum)
- Exposure to a known risk factor for COPD (such as tobacco smoke)
- If available, respiratory function tests showing non- or partially reversible obstructive syndrom (post-bronchodilator ratio FEV1/CV \< 0.7)
- Severe acute exacerbation, defined as a worsening of the patient's usual respiratory symptoms with signs of acute respiratory distress (polypnoea ≥ 30 cycles.min-1 or use of accessory respiratory muscles) and/or hypercapnic acidosis (with PaCO2 ≥ 45 mmHg and pH ≤ 7.35)
- Admission to an ICU, a step-up unit or a respiratory care unit
Exclusion criteria
- Known asthma (according to the criteria of the international "Global initiative for asthma" guidelines)
- Patient refusal to participate (information note, application for non-opposition)
Where it is running
2 locations listed.
- Centre hospitalier de Versailles - Le Chesnay, France
- CH Le Mans - Le Mans, France